跳至主要内容
临床试验/NCT03562663
NCT03562663
已完成
不适用

Transcranial Direct Current Stimulation and Robotic Training in Chronic Stroke

Burke Medical Research Institute0 个研究点目标入组 82 人2012年1月

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Chronic Stroke
发起方
Burke Medical Research Institute
入组人数
82
主要终点
Change From Baseline in Upper Limb Fugl Meyer Score
状态
已完成
最后更新
5年前

概览

简要总结

Motor skill training and transcranial direct current stimulation (tDCS) have separately been shown to alter cortical excitability and enhance motor function in humans. Their combination is appealing for augmenting motor recovery in stroke patients, and this is an area presently under heavy investigation globally. The investigators have previously shown that the timing of tDCS application has functional significance, that tDCS applied prior to training can be beneficial for voluntary behavior, and that tDCS effects may not simply be additive to training effects, but may change the nature of the training effect. The investigators have separately reported in a randomized-controlled clinical trial, that upper limb robotic training alone over 12 weeks can improve clinical function of chronic stroke patients. Based on our results with tDCS and robotic training, the investigators hypothesize that the same repeated sessions of robotic training, but preceded by tDCS, would lead to a sustained and functional change greater than robotic training alone. The investigators will determine if clinical function can be improved and sustained with tDCS-robotic training and cortical physiology changes that underlie functional improvements.

详细描述

The primary aim of this study is to evaluate whether multiple sessions of combined tDCS and robotic upper limb training in chronic hemiplegia, leads to clinical improvement in upperlimb motor impairment. In chronic stroke patients (\>6months post-injury, stable unilateral motor deficit) using a within-subjects repeated-measures design we will evaluate the effects of 12 weeks of robotic upperlimb training (3x/week, 36 sessions, shoulder/elbow/wrist in each session) with real or sham tDCS before the robotic training. Clinical improvement will be determined by a change in upper-limb Fugl-Meyer (primary), the Medical Research Council motor power score (MRC), Wolf Motor Function Test, Barthel Index, and Stroke Impact Scale (secondary) outcome measures following the training, and assessed again six months later. The investigators further aim to identify and compare the neurophysiological characteristics between intervention groups. The relationship between clinical improvement and neurophysiological measures pertaining to robotic motor training following stroke are presently not described in the literature. By measuring the EMG response from forearm musculature to Transcranial Magnetic Stimulation the investigators will establish: (i) plasticity associated with training, and (ii) the neurophysiological characteristics of patients who respond to training. By understanding how brain excitability changes underpin motor dysfunction, and motor recovery, interventions can be more effectively prescribed and prognoses established.

注册库
clinicaltrials.gov
开始日期
2012年1月
结束日期
2016年12月
最后更新
5年前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

发起方
Burke Medical Research Institute
责任方
Principal Investigator
主要研究者

Dylan Edwards

Lab Director, Laboratory for Non-Invasive Brain Stimulation and Human Motor Control

Burke Medical Research Institute

入排标准

入选标准

  • A first single focal unilateral lesion with diagnosis verified by brain imaging (MRI or CT scans) that occurred at least 6 months prior;
  • Ability to follow 1-2 step commands
  • Fugl-Meyer assessment of 7 to 58 out of 66 (neither hemiplegic nor fully recovered motor function in the muscles of the shoulder and elbow and wrist).

排除标准

  • A fixed contraction deformity in the affected limb;
  • A complete and total flaccid paralysis of all shoulder and elbow motor performance;
  • A hemorrhagic stroke
  • Presence of tDCS / TMS risk factors
  • Presence of an electrically, magnetically or mechanically activated implant (including cardiac pacemaker), an intracerebral vascular clip, or any other electrically sensitive support system
  • A history of medication-resistant epilepsy in the family
  • Past history of seizures or unexplained spells of loss of consciousness

结局指标

主要结局

Change From Baseline in Upper Limb Fugl Meyer Score

时间窗: Baseline and after the 12-week intervention

Upper limb fugl Meyer score is a measure of upper extremity motor weakness on a 66-point scale. Fugl Meyer score range: 0-66. Higher scores indicate better outcome. Units: Units on a scale.

相似试验